ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,964
Screening encounters
2,114
Diagnostic referrals
406
Outstanding pathways
178

Screening pathway

  1. Screening2,114Encounters
  2. Positive finding712Documented findings
  3. Referral406Diagnostic referrals
  4. Follow-up434Diagnostic visits
  5. Outcome228Resolved pathways

Stage totals use different units. Pending pathways: 178. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0433 · EXP-0433Synthetic · Site B

Full participant history through 2025-12-17, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA positive
  4. · Diagnostic referral · EXP-0433-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Missed
  8. · Diagnostic booking · Rebooking
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-09-24
  13. · Follow-up disposition · Resolved · EXP-0433-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

1964 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0408 · Expanded synthetic participant 0408Site B — Peri-Urban Access Programme
EXP-0410 · Expanded synthetic participant 0410Site B — Peri-Urban Access Programme
EXP-0413 · Expanded synthetic participant 0413Site E — Resource-Constrained Navigation Programme
EXP-0414 · Expanded synthetic participant 0414Site A — Urban Referral Hub
EXP-0417 · Expanded synthetic participant 0417Site D — Community Engagement Programme
EXP-0418 · Expanded synthetic participant 0418Site A — Urban Referral Hub
EXP-0419 · Expanded synthetic participant 0419Site D — Community Engagement Programme
EXP-0420 · Expanded synthetic participant 0420Site E — Resource-Constrained Navigation Programme
EXP-0421 · Expanded synthetic participant 0421Site C — Rural Outreach Programme
EXP-0426 · Expanded synthetic participant 0426Site D — Community Engagement Programme
EXP-0433 · Expanded synthetic participant 0433Site B — Peri-Urban Access Programme
EXP-0435 · Expanded synthetic participant 0435Site D — Community Engagement Programme
EXP-0438 · Expanded synthetic participant 0438Site C — Rural Outreach Programme
EXP-0439 · Expanded synthetic participant 0439Site A — Urban Referral Hub
EXP-0440 · Expanded synthetic participant 0440Site E — Resource-Constrained Navigation Programme
EXP-0441 · Expanded synthetic participant 0441Site B — Peri-Urban Access Programme
EXP-0442 · Expanded synthetic participant 0442Site C — Rural Outreach Programme
EXP-0443 · Expanded synthetic participant 0443Site C — Rural Outreach Programme
EXP-0446 · Expanded synthetic participant 0446Site B — Peri-Urban Access Programme
EXP-0447 · Expanded synthetic participant 0447Site C — Rural Outreach Programme
EXP-0448 · Expanded synthetic participant 0448Site E — Resource-Constrained Navigation Programme
EXP-0450 · Expanded synthetic participant 0450Site A — Urban Referral Hub
EXP-0454 · Expanded synthetic participant 0454Site D — Community Engagement Programme
EXP-0456 · Expanded synthetic participant 0456Site A — Urban Referral Hub
EXP-0457 · Expanded synthetic participant 0457Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
901
HPV DNA
907
Cytology
306

Navigation activity

Barrier documented
331
Contact attempt
600
Navigation intervention
133
Diagnostic booking
494
Diagnostic visit
434

Documented barriers

Contact difficulty
97
Transport difficulty
113
Appointment coordination
121

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.